Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan Qin

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
Oncotargets and Therapy|March 30, 2016
The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese populationNan Sha, Hao Xu, Tao Chen, et al.
Journal of Gastrointestinal Oncology|January 10, 2024
A methylation-related signature for predicting prognosis and sensitivity to first-line therapies in gastric cancerChenlin Cao, Zhiyong Luo, Hong Zhang, et al.
World Journal of Gastroenterology|October 1, 2015
Recql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in miceWan-Qin Liao, Ya-Lei Qi, Lin Wang, et al.
Stem Cell Research & Therapy|September 25, 2019
miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cellsChen-Fei Zhou, Min-Juan Liu, Wei Wang, et al.
Oncology|January 13, 2021
Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World ExperienceJoseph J Zhao, Nesaretnam Barr Kumarakulasinghe, Vaishnavi Muthu, et al.
Stem Cell Research & Therapy|May 22, 2020
Correction to: miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cellsChen-Fei Zhou, Min-Juan Liu, Wei Wang, et al.
Oral Oncology|June 19, 2018
Interobserver variations in the delineation of target volumes and organs at risk and their impact on dose distribution in intensity-modulated radiation therapy for nasopharyngeal carcinomaYing-Lin Peng, Li Chen, Guan-Zhu Shen, et al.
Hepatology International|November 20, 2023
Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathwayFu Wang, Wei-Qi Xu, Wan-Qin Zhang, et al.
Journal of Cancer Research and Clinical Oncology|April 29, 2022
Individualized clinical target volume delineation and efficacy analysis in unilateral nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT): 10-year summaryDe-Huan Xie, Zheng Wu, Wang-Zhong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2026
A multicentre phase 2 study of trifluridine/tipiracil in recurrent/metastatic platinum resistant nasopharyngeal carcinomasJia Li Low, Wan Qin Chong, Edwin Pun Hui, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
Oncotargets and Therapy|March 30, 2016
The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese populationNan Sha, Hao Xu, Tao Chen, et al.
Journal of Gastrointestinal Oncology|January 10, 2024
A methylation-related signature for predicting prognosis and sensitivity to first-line therapies in gastric cancerChenlin Cao, Zhiyong Luo, Hong Zhang, et al.
World Journal of Gastroenterology|October 1, 2015
Recql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in miceWan-Qin Liao, Ya-Lei Qi, Lin Wang, et al.
Stem Cell Research & Therapy|September 25, 2019
miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cellsChen-Fei Zhou, Min-Juan Liu, Wei Wang, et al.
Oncology|January 13, 2021
Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World ExperienceJoseph J Zhao, Nesaretnam Barr Kumarakulasinghe, Vaishnavi Muthu, et al.
Stem Cell Research & Therapy|May 22, 2020
Correction to: miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cellsChen-Fei Zhou, Min-Juan Liu, Wei Wang, et al.
Oral Oncology|June 19, 2018
Interobserver variations in the delineation of target volumes and organs at risk and their impact on dose distribution in intensity-modulated radiation therapy for nasopharyngeal carcinomaYing-Lin Peng, Li Chen, Guan-Zhu Shen, et al.
Hepatology International|November 20, 2023
Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathwayFu Wang, Wei-Qi Xu, Wan-Qin Zhang, et al.
Journal of Cancer Research and Clinical Oncology|April 29, 2022
Individualized clinical target volume delineation and efficacy analysis in unilateral nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT): 10-year summaryDe-Huan Xie, Zheng Wu, Wang-Zhong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2026
A multicentre phase 2 study of trifluridine/tipiracil in recurrent/metastatic platinum resistant nasopharyngeal carcinomasJia Li Low, Wan Qin Chong, Edwin Pun Hui, et al.
Pageof 24